Surgery Partners (NASDAQ:SGRY) Stock Price Target Raised at Royal Bank Of Canada

Key Points

• Royal Bank of Canada raised its price target on Surgery Partners from $23.50 to $25, maintaining a “sector perform” rating; the target implies 6.44% downside from the stock’s then-current price.
• Analyst sentiment is broadly cautious: the consensus rating is “Hold,” with an average price target of $20.27, and several firms recently downgraded the stock.
• Surgery Partners reported quarterly EPS of $0.16, beating estimates of $0.11, but revenue of $815.3 million missed forecasts and declined 0.8% year over year.

Surgery Partners (NASDAQ:SGRY - Get Free Report) had its price objective boosted by stock analysts at Royal Bank Of Canada from $23.50 to $25.00 in a report issued on Tuesday, Benzinga reports. The brokerage currently has a "sector perform" rating on the stock. Royal Bank Of Canada's target price suggests a potential downside of 6.44% from the company's current price.

A number of other research analysts have also recently commented on the company. Cantor Fitzgerald cut Surgery Partners from an "overweight" rating to a "hold" rating in a research note on Monday, October 26th. TD Cowen lowered Surgery Partners from a "strong-buy" rating to a "hold" rating in a research report on Saturday, October 31st. Stonex Financial downgraded shares of Surgery Partners from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 27th. JPMorgan Chase & Co. raised their target price on Surgery Partners from $14.00 to $15.00 and gave the company a "neutral" rating in a research note on Monday, September 14th. Finally, Weiss Ratings raised Surgery Partners from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, October 16th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $20.27.

Surgery Partners Trading Up 1.0%

NASDAQ SGRY traded up $0.27 during trading hours on Tuesday, hitting $26.72. 817,093 shares of the company's stock were exchanged, compared to its average volume of 2,222,740. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $27.23. The business's 50 day moving average is $16.29 and its 200-day moving average is $14.88. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The firm has a market capitalization of $3.50 billion, a P/E ratio of -38.22 and a beta of 1.85.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.05. The business had revenue of $815.30 million for the quarter, compared to analyst estimates of $820.96 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company's revenue was down .8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.13 EPS. As a group, analysts anticipate that Surgery Partners will post 0.07 EPS for the current fiscal year.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa DeLuca acquired 10,000 shares of the company's stock in a transaction dated Tuesday, August 18th. The shares were acquired at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the purchase, the director owned 66,843 shares of the company's stock, valued at approximately $959,197.05. This trade represents a 17.59% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.00% of the stock is owned by company insiders.

Institutional Trading of Surgery Partners

A number of institutional investors and hedge funds have recently modified their holdings of SGRY. Jefferies Financial Group Inc. acquired a new stake in shares of Surgery Partners in the third quarter valued at $560,000. Vise Technologies Inc. acquired a new stake in shares of Surgery Partners during the third quarter worth $191,000. State of Wyoming boosted its stake in Surgery Partners by 51.4% during the 3rd quarter. State of Wyoming now owns 23,568 shares of the company's stock worth $327,000 after acquiring an additional 7,997 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Surgery Partners in the third quarter valued at approximately $426,000. Finally, Inspire Investing LLC raised its stake in Surgery Partners by 10.1% during the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company's stock worth $621,000 after buying an additional 4,099 shares during the period.

Surgery Partners News Summary

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Higher merger price is the main catalyst. The amended agreement reportedly increases the per-share consideration to $25 from $23.50 after a competing bid, with the Bon Secours affiliate’s transaction valued at up to $6 billion. A higher offer supports the deal’s value for shareholders, though completion remains a risk. Article: Surgery Partners Secures Improved Merger Terms
• Positive Sentiment: Adjusted Q3 earnings topped estimates. Surgery Partners reported adjusted EPS of $0.16, above the cited FactSet estimate of $0.11, providing some earnings support. Article: Q3 Adjusted EPS Earnings Flash
• Neutral Sentiment: Cash generation improved, despite weaker operating results. Operating cash flow was reported at $103.5 million and cash balances rose to $354.5 million, while revenue was $815.3 million—below estimates and slightly down year over year. Article: Q3 2026 Earnings Results
• Negative Sentiment: Profitability remains a concern, and a cash-flow valuation flags downside. The company reported a $21.1 million net loss attributable to common shareholders, with higher costs and lower operating profit. A separate analysis estimates SGRY may be 13% overvalued based on cash flow, which could limit further gains. Article: Surgery Partners Stock Could Be 13% Overvalued on Cash Flow

Surgery Partners Company Profile

Surgery Partners, Inc is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties.

The company's services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States.

Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.